• Cancer cell therapy pioneer Allogene’s new CEO is talking about a new revolution The Business Journals Thu, 09 Jul 2026 13:14:00 GMT
• Form 4 Allogene Therapeutics Inc For: 6 July By Investing.com Investing.com Canada Mon, 06 Jul 2026 22:05:26 GMT
• Allogene Therapeutics (ALLO) CEO granted 476,190 options and 134,530 RSUs Stock Titan Mon, 06 Jul 2026 21:51:42 GMT
• ALLO Stock Hits 2-Year Highs – Analyst Calls Allogene’s Phase 2 Trial Data To Treat Lymphoma A ‘Home Run’ Stocktwits Sun, 05 Jul 2026 04:54:52 GMT
• Allogene Therapeutics shows promise with ALPHA3 trial and ALLO-329, cutting losses and extending cash runway. Pluang Sat, 04 Jul 2026 14:30:25 GMT
• Allogene Therapeutics: High-Upside Bet On The Next Wave Of CAR-T Innovation (NASDAQ:ALLO) Seeking Alpha Sat, 04 Jul 2026 14:10:17 GMT
• allogene at h.c. wainwright conference: cema-cel data lift strategy Investing.com Tue, 30 Jun 2026 21:18:53 GMT
• Enterprise value to EBITDA forward of Allogene Therapeutics, Inc. – NASDAQ:ALLO TradingView Sun, 28 Jun 2026 07:34:17 GMT
• Allogene Therapeutics (ALLO) Stock Gets Fair Value Boost After Split Analyst Revisions Yahoo Finance Sun, 28 Jun 2026 07:00:00 GMT
• Price to earnings forward of Allogene Therapeutics, Inc. – NASDAQ:ALLO TradingView Sat, 27 Jun 2026 22:43:20 GMT
• enterprise value to ebitda forward of allogene therapeutics, inc. – boats:allo TradingView Sat, 27 Jun 2026 22:15:12 GMT
• enterprise value to revenue forward of allogene therapeutics, inc. – boats:allo TradingView Sat, 27 Jun 2026 20:02:43 GMT
• price to book forward of allogene therapeutics, inc. – nasdaq:allo TradingView Sat, 27 Jun 2026 17:22:22 GMT
• enterprise value to ebit forward of allogene therapeutics, inc. – nasdaq:allo TradingView Sat, 27 Jun 2026 14:13:11 GMT
• allo stock hits 2-year highs – analyst calls allogene’s phase 2 trial data to treat lymphoma a ‘home run’ Stocktwits Sat, 27 Jun 2026 13:56:31 GMT
• price to sales forward of allogene therapeutics, inc. – nasdaq:allo TradingView Sat, 27 Jun 2026 13:16:32 GMT
• allogene therapeutics, inc. actuals & estimates (nasdaq:allo) TradingView Fri, 26 Jun 2026 04:05:18 GMT
• why is allogene therapeutics (allo) down 12.2% since last earnings report? MSN Fri, 26 Jun 2026 03:48:45 GMT
• allogene therapeutics (allo) short interest & short float | updated jun 2026 $allo MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• allo stock hits 2-year highs – analyst calls allogene’s phase 2 trial data to treat lymphoma a ‘home run’ Stocktwits Wed, 24 Jun 2026 19:40:18 GMT
• form 4 allogene therapeutics inc for: 23 june by investing.com Investing.com South Africa Tue, 23 Jun 2026 20:57:01 GMT
• Allogene (ALLO) director Owen Witte awarded 95,400 RSUs with deferred delivery Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Allogene Therapeutics (ALLO) director receives 144,400 stock options grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Allogene Therapeutics (ALLO) director receives 95,400 RSU equity award Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• [Form 4] Allogene Therapeutics, Inc. Insider Trading Activity Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Allogene Therapeutics (NASDAQ: ALLO) grants director 95,400 RSUs Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Allogene (ALLO) director awarded 95,400 RSUs with deferred share delivery Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• Allogene (ALLO) director Kazam converts 47,700 RSUs and receives 95,400-unit equity grant Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• form 424b5 allogene therapeutics inc for: 22 june by investing.com Investing.com South Africa Mon, 22 Jun 2026 21:28:26 GMT
• Allogene Therapeutics (NASDAQ: ALLO) doubles authorized shares and files $135M ATM plan Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Allogene (NASDAQ: ALLO) launches $135M ATM program with TD Cowen at $2.00 ref Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• why is allogene therapeutics (allo) down 12.2% since last earnings report? MSN Sat, 20 Jun 2026 21:19:47 GMT
• allogene therapeutics activates first clinical sites for pivotal phase 2 trial of cema-cel CRISPR Medicine News Fri, 19 Jun 2026 20:52:46 GMT
• allo: all proposals, including director elections and share increase, were approved without contest TradingView Thu, 18 Jun 2026 15:54:19 GMT
• allo: all proposals passed, including director elections and share authorization increase TradingView Thu, 18 Jun 2026 15:52:19 GMT
• allogene therapeutics inc (allo) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) institutional confidence TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 18:27:32 GMT
• allogene therapeutics inc (allo) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:27:19 GMT
• allogene therapeutics inc (allo) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 17:51:37 GMT
• How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 00:23:16 GMT
• allogene therapeutics inc (allo) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 00:23:11 GMT
• allogene therapeutics inc (allo) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 23:57:14 GMT
• 10 small cap stocks with potential to rise 1000 percent Insider Monkey Tue, 16 Jun 2026 14:27:09 GMT
• why is allogene therapeutics (allo) down 12.2% since last earnings report? MSN Tue, 16 Jun 2026 06:49:52 GMT
• allogene therapeutics stock surges on optimistic trial results and price target increase timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT
• allogene therapeutics inc (allo) risk assessment: volatility, financial risk & investment risk TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• why is allogene therapeutics (allo) down 12.2% since last earnings report? MSN Mon, 15 Jun 2026 06:12:57 GMT
• allo stock hits 2-year highs – analyst calls allogene’s phase 2 trial data to treat lymphoma a ‘home run’ Stocktwits Sun, 14 Jun 2026 00:27:23 GMT
• allo q1 2026 earnings: smaller-than-expected loss surprises positively; stock gains - profit announcement newsline.com Fri, 12 Jun 2026 18:42:28 GMT
• allo stock hits 2-year highs – analyst calls allogene’s phase 2 trial data to treat lymphoma a ‘home run’ Stocktwits Fri, 12 Jun 2026 10:18:39 GMT
• Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report? Yahoo Finance Fri, 12 Jun 2026 07:00:00 GMT
• car t-cell therapy for non-hodgkin’s lymphoma market emerging as a high-growth healthcare investment space through 2036 – delveins... Barchart.com Fri, 12 Jun 2026 00:54:14 GMT
• allogene therapeutics: car t-cell pipeline attracts investor interest in penny stock arena - earnings beat streak newsline.com Tue, 09 Jun 2026 05:34:33 GMT
• Allogene Therapeutics, Inc. (ALLO) A Top Penny Stock to Buy on Robust CAR T-Cell Portfolio Yahoo Finance Sun, 07 Jun 2026 07:00:00 GMT
• allo q1 2026 earnings: narrower-than-expected loss highlights progress in car-t pipeline - high estimate range newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• allo q1 2026 earnings: narrower-than-expected loss drives modest stock appreciation - profit recovery report newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• a pioneering founder is stepping down as ceo of his bay area company ahead of a major test The Business Journals Mon, 01 Jun 2026 07:00:00 GMT
• certain restricted stock units of allogene therapeutics, inc. are subject to a lock-up agreement ending on 30-may-2026. marketscreener.com Sat, 30 May 2026 00:21:59 GMT
• certain common stock of allogene therapeutics, inc. are subject to a lock-up agreement ending on 30-may-2026. marketscreener.com Sat, 30 May 2026 00:21:45 GMT
• allogene therapeutics, inc. 8-k sec filing may 28, 2026: company details, common stock, and exchange information Minichart Fri, 29 May 2026 15:07:00 GMT
• Allogene swaps in CMO as new chief exec—Chutes & Ladders Fierce Biotech Fri, 29 May 2026 07:00:00 GMT
• Certain Common Stock of Allogene Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2026. marketscreener.com Fri, 29 May 2026 07:00:00 GMT
• piper sandler maintains allogene therapeutics(allo.us) with buy rating, maintains target price $10 Moomoo Fri, 29 May 2026 07:00:00 GMT
• allogene therapeutics names zachary roberts as new ceo The Globe and Mail Fri, 29 May 2026 07:00:00 GMT
• allo q1 2026 earnings: narrower loss than expected but stock declines - ceo earnings statement newsline.com Fri, 29 May 2026 07:00:00 GMT
• david chang to hand over the reins at allogene; ex-esperion ceo gets started at phlow Endpoints News Fri, 29 May 2026 07:00:00 GMT
• allogene therapeutics names zachary roberts ceo in planned succession MSN Fri, 29 May 2026 03:49:56 GMT
• allogene therapeutics names jared gollob ceo, effective july 1, 2026 geneonline.com Fri, 29 May 2026 02:12:00 GMT
• Allogene Therapeutics Announces Planned CEO Succession GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• Allogene Therapeutics (ALLO) elevates Zachary Roberts to CEO with major equity awards Stock Titan Thu, 28 May 2026 07:00:00 GMT
• Press Release: Allogene Therapeutics Announces Planned CEO Succession Moomoo Thu, 28 May 2026 07:00:00 GMT
• allogene therapeutics (allo) announces leadership transition GuruFocus Thu, 28 May 2026 07:00:00 GMT
• allogene therapeutics names zachary roberts as new ceo Investing.com Thu, 28 May 2026 07:00:00 GMT
• allogene therapeutics, inc. announces ceo changes marketscreener.com Thu, 28 May 2026 07:00:00 GMT
• ALLO Stock Steadies As Cash Runway Extends To 2029 On Trial Progress StocksToTrade Wed, 27 May 2026 07:00:00 GMT
• allogene therapeutics (allo) surges 6%: can the biotech reclaim key resistance? - vanna flow newsline.com Wed, 27 May 2026 07:00:00 GMT
• cancer cell therapy firm allogene lines up three investor talks Stock Titan Tue, 26 May 2026 12:30:00 GMT
• Allogene Therapeutics Announces Participation in Upcoming Investor Conferences Allogene Tue, 26 May 2026 07:00:00 GMT
• a quick look at today's ratings for allogene therapeutics(allo.us), with a forecast between $9 to $14 富途牛牛 Thu, 21 May 2026 23:48:24 GMT
• allogene’s universal trial completion: what allo-715 data could mean for investors TipRanks Thu, 21 May 2026 13:12:10 GMT
• allogene therapeutics - 2026 funding rounds & list of investors Tracxn Wed, 20 May 2026 15:58:17 GMT
• jpmorgan, allogene therapeutics and other big stocks moving lower in tuesday's pre-market session MSN Wed, 20 May 2026 12:51:40 GMT
• Earnings call transcript: Allogene Therapeutics Q1 2026 sees mixed results with revenue miss Investing.com Wed, 20 May 2026 07:00:00 GMT
• allo technical analysis | trend, signals & chart patterns | allogene therapeutics inc (nasdaq:allo) ChartMill Tue, 19 May 2026 07:00:00 GMT
• jpmorgan, allogene therapeutics and other big stocks moving lower in tuesday's pre-market session MSN Sun, 17 May 2026 22:34:39 GMT
• number of shareholders of allogene therapeutics, inc. – boats:allo TradingView Sun, 17 May 2026 06:37:43 GMT
• allogene’s universal trial completion: what allo-715 data could mean for investors TipRanks Sun, 17 May 2026 04:13:01 GMT
• allogene outlines cash runway into q1 2029 while raising 2026 operating cash expense guidance to ~$165m MSN Sat, 16 May 2026 00:45:44 GMT
• allogene therapeutics unveils allo-329 with dagger technology for next generation cell therapy Traders Union Fri, 15 May 2026 23:19:23 GMT
• allogene therapeutics, inc. (nasdaq:allo) q1 2026 earnings call transcript Insider Monkey Fri, 15 May 2026 12:40:25 GMT
• piper sandler sticks to their buy rating for allogene therapeutics (allo) The Globe and Mail Fri, 15 May 2026 11:37:27 GMT
• canaccord genuity remains a buy on allogene therapeutics (allo) The Globe and Mail Fri, 15 May 2026 11:36:00 GMT
• citadel affiliates, kenneth griffin report stakes in allogene (allo) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lynx1 amends 13g for allogene therapeutics (nasdaq: allo) showing 0% stake Stock Titan Fri, 15 May 2026 07:00:00 GMT
• a quick look at today's ratings for allogene therapeutics(allo.us), with a forecast between $7 to $14 Moomoo Fri, 15 May 2026 07:00:00 GMT
• analysts’ top healthcare picks: allogene therapeutics (allo), evommune, inc. (evmn) The Globe and Mail Fri, 15 May 2026 02:00:00 GMT
• allogene therapeutics (nasdaq:allo) shares down 7.7% - here's what happened MarketBeat Thu, 14 May 2026 18:24:05 GMT
• allogene’s universal trial completion: what allo-715 data could mean for investors TipRanks Thu, 14 May 2026 16:38:02 GMT
• oppenheimer maintains allogene therapeutics(allo.us) with buy rating, maintains target price $7 Moomoo Thu, 14 May 2026 15:28:25 GMT
• rbc capital maintains allogene therapeutics(allo.us) with buy rating, maintains target price $9 Moomoo Thu, 14 May 2026 14:28:49 GMT
• big pharma’s 5 hottest biotech hunting grounds: meet the category leaders 24/7 Wall St. Thu, 14 May 2026 13:20:55 GMT
• piper sandler maintains allogene therapeutics(allo.us) with buy rating, maintains target price $10 Moomoo Thu, 14 May 2026 12:52:12 GMT
• allogene therapeutics ends china cell therapy deal with overland MSN Thu, 14 May 2026 09:48:57 GMT
• allogene therapeutics inc (allo) q1 2026 earnings call highlights: promising trial results and financial strength GuruFocus Thu, 14 May 2026 09:00:51 GMT
• Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1 Zacks Investment Research Thu, 14 May 2026 07:00:00 GMT
• a quick look at today's ratings for allogene therapeutics(allo.us), with a forecast between $9 to $14 Moomoo Thu, 14 May 2026 07:00:00 GMT
• td cowen maintains allogene therapeutics(allo.us) with buy rating Moomoo Thu, 14 May 2026 03:30:41 GMT
• allogene therapeutics reports q1 eps (18c), consensus (18c) TipRanks Thu, 14 May 2026 02:34:51 GMT
• allogene therapeutics q1 earnings call highlights The Globe and Mail Thu, 14 May 2026 00:13:00 GMT
• allogene therapeutics increases 2026 operating cash expense guidance TipRanks Wed, 13 May 2026 23:01:47 GMT
• allogene therapeutics options imply 10.6% move in share price post-earnings TipRanks Wed, 13 May 2026 22:53:28 GMT
• allo: interim data show robust efficacy and safety for cema-cel and early promise for allo-329, with solid financials TradingView Wed, 13 May 2026 22:27:04 GMT
• allogene therapeutics releases q1 corporate update with focus on allogeneic cell therapy progress Traders Union Wed, 13 May 2026 22:01:52 GMT
• allogene therapeutics pone fine ad accordo sulla terapia cellulare in cina con overland TradingView Wed, 13 May 2026 21:01:51 GMT
• Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• Allogene Therapeutics Q1 2026 Earnings Call Transcript Yahoo Finance Wed, 13 May 2026 07:00:00 GMT
• Is Allogene Therapeutics (ALLO) Undervalued After Q1 2026? EPS - GuruFocus Wed, 13 May 2026 07:00:00 GMT
• Allogene Therapeutics Inc (ALLO) Q1 2026 Earnings Call Highlights: Promising Trial Results and Financial Strength GuruFocus Wed, 13 May 2026 07:00:00 GMT
• earnings call transcript: allogene therapeutics beats eps expectations in q1 2026 Investing.com Wed, 13 May 2026 07:00:00 GMT
Allogene Therapeutics, Inc(NASDAQ:ALLO) 
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candi...
Website: http://www.allogene.com
Founded: 2017
Full Time Employees: 264
Sector: Healthcare
Industry: Biotechnology